首页> 外国专利> PHARMACEUTICAL COMPOSITIONS CONTAINING ANG- (1-7) OR OTHER RECEIVER AGONISTS BUT WITH COMBINATION WITH PI3K / AKT INHIBITORS FOR ANTICCAN THERAPEUTIC TREATMENT

PHARMACEUTICAL COMPOSITIONS CONTAINING ANG- (1-7) OR OTHER RECEIVER AGONISTS BUT WITH COMBINATION WITH PI3K / AKT INHIBITORS FOR ANTICCAN THERAPEUTIC TREATMENT

机译:包含Ang-(1-7)或其他受体激动剂的药物组合物,但与PI3K / AKT抑制剂组合可用于止痛药的治疗

摘要

PHARMACEUTICAL COMPOSITIONS CONTAINING ANG- (1-7) OR OTHER RECEIVER AGONIST BUT IN COMBINATION WITH PI3K / AKT INHIBITORS FOR ANTICCANE THERAPEUTIC TREATMENT This invention describes pharmaceutical compositions containing a combination of Ang- (1-7) or other receptor agonist. But with PI3K / Akt inhibitors, for anticancer therapeutic treatment. The combination of Ang- (1-7) and PI3K / Akt inhibitors results in inhibition of cancer progression through inhibition of cell growth or proliferation or activation of apoptosis cell death in mammals, particularly humans.
机译:包含Ang-(1-7)或其他受体激动剂但与PI3K / AKT抑制剂组合用于抗风疹治疗的药物组合物本发明描述了包含Ang-(1-7)或其他受体激动剂的组合的药物组合物。但要与PI3K / Akt抑制剂配合,进行抗癌治疗。 Ang-(1-7)和PI3K / Akt抑制剂的组合可通过抑制哺乳动物,特别是人类的细胞生长或增殖或激活凋亡的细胞死亡来抑制癌症进展。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号